Home  > 
  Abcam, TTP Labtech collaborate to develop sol-R reagent kits,   August 21, 2017
  Seattle Sperm Bank introduces comprehensive genetic testing search tool,   August 19, 2017
  BiondVax receives NIS 2.7 mn funding from Israel Innovation Authority to develop its universal flu vaccine candidate, M-001,   August 17, 2017
  BIRAC invites research proposals from start-up biotech cos under BIG scheme,   August 12, 2017
  MimiVax's brain cancer vaccine, SurVaxM receives US FDA orphan drug status,   August 10, 2017
  IAN signs MoU with BIRAC to gain market access and investments,   August 08, 2017
  LifeCell preserves over 5,000 units of cord blood stem cells for unrelated use,   August 07, 2017
  Evotec inks strategic collaboration on iPSC technology with Fraunhofer IME-SP,   August 05, 2017
  Agilis Biotherapeutics, GTRI ink JV to advance gene therapy manufacturing,   August 04, 2017
  Experts see draft national guidelines for stem cell research to stall unproven therapies in India,   August 03, 2017
  Amgen, Allergan submit BLA to US FDA for biosimilar candidate to trastuzumab,   August 02, 2017
  TTP & New England Biolabs ink partnership to offer services to molecular diagnostics technology developers,   August 01, 2017
  Convergence of IT & BT leads to a different kind of innovation: Kiran Mazumdar-Shaw,   July 29, 2017
  Revised draft National Guidelines for Stem Cell Research prohibits several areas of research in stem cell,   July 24, 2017
  BIRAC invites fresh proposals from biotech cos under BIPP scheme,   July 21, 2017
  ViraCyte inks licensing pact with Baylor College of Medicine for virus-specific T cell therapy technology,   July 20, 2017
  Genome therapy with beneficial natural mutation could lead to new treatment for life-threatening blood disorders: Study,   July 19, 2017
  WHO/UNICEF data shows 1 in 10 infants worldwide did not receive any vaccinations in 2016,   July 18, 2017
  Sphere Fluidics and partners to receive InnovateUK grant of $1.25 to develop new automated single cell genome engineering platform,   July 18, 2017
  Emergent BioSolutions to buy smallpox vaccine business, ACAM2000 from Sanofi for $125 million,   July 17, 2017

Copyright © 2016 Saffron Media Pvt. Ltd |